Maintaining Antiviral Efficacy After Switching to Generic Entecavir 1 mg for Chronic Hepatitis B
NCT04069858
·
clinicaltrials.gov ↗
PHASE4
Phase
UNKNOWN
Status
40
Enrollment
OTHER
Sponsor class
Conditions
Chronic Hepatitis B
Interventions
DRUG:
Switching to Generic Entecavir (Baracle®)
Sponsor
Korea University